SCHEMBL6996839

SCHEMBL6996839

CCOC(=O)c1cc(C)c(CC[C@H]2CNc3nc(N)[nH]c(=O)c3S2)s1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GART P22102 7/20 0.66
FOLR1 P15328 3/20 0.66
MAPK1 P28482 1/20 0.34
KDM4E B2RXH2 3/20 0.32
NOS1 P29475 3/20 0.32
ALDH1A1 P00352 2/20 0.32
GAA P10253 2/20 0.32
HPGD P15428 2/20 0.32
TSHR P16473 2/20 0.32
HSD17B10 Q99714 1/20 0.32
NOS3 P29474 1/20 0.32
NOS2 P35228 1/20 0.32
ATIC P31939 1/20 0.32
CYP1A2 P05177 1/20 0.31
POLB P06746 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
USP2 O75604 1/20 0.31
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6991867 0.89 GART (0.72) GARTFOLR1NOS1HSD17B10NOS3
SCHEMBL6993317 0.89 GART (0.72) GARTFOLR1NOS1HSD17B10NOS3
SCHEMBL8537889 0.80 GART (0.63) GARTFOLR1MAPK1ATIC
SCHEMBL7145433 0.76 GART (0.80) GARTFOLR1ATIC
SCHEMBL22967335 0.73 GART (0.59) GARTFOLR1KDM4ENOS1ALDH1A1
SCHEMBL8362067 0.73 GART (0.53) GARTFOLR1KDM4ENOS1ALDH1A1
SCHEMBL7812453 0.71 GART (0.69) GARTFOLR1NOS1ATIC
SCHEMBL6994470 0.68 ALDH1A1 (0.40) MAPK1KDM4EALDH1A1GAAHPGD
Pelitrexol SCHEMBL13927981 0.64 GART (0.74) GARTFOLR1ATIC
SCHEMBL6919868 0.63 HDAC3 (0.43) MAPK1KDM4EALDH1A1GAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0846111-B1 SYNTHESES OF OPTICALLY PURE COMPOUNDS USEFUL AS GARFT INHIBITORS AND THEIR INTERMEDIATES AGOURON PHARMA (US) 2003-08-27 EP disclosed
US-5981748-A Synthesis of optically pure compounds useful as GARFT inhibitors and their intermediates AGOURON PHARMACEUTICALS, INC. (US) 1999-11-09 US disclosed
EP-0846111-A1 SYNTHESES OF OPTICALLY PURE COMPOUNDS USEFUL AS GARFT INHIBITORS AND THEIR INTERMEDIATES AGOURON PHARMACEUTICALS, INC. (US) 1998-06-10 EP disclosed
WO-1996040674-A1 SYNTHESES OF OPTICALLY PURE COMPOUNDS USEFUL AS GARFT INHIBITORS AND THEIR INTERMEDIATES AGOURON PHARMACEUTICALS, INC. (US) 1996-12-19 WO disclosed